Science 37

Science 37 is a trailblazing, highly innovative clinical research company that fundamentally disrupted the traditional pharmaceutical industry by pioneering the Decentralized Clinical Trial (DCT) and agile trial models. Founded with the core mission to democratize clinical research and put patients first, Science 37 enables universal access for patients, regardless of their geographic location, socioeconomic status, or proximity to a major research hospital.

Their proprietary, end-to-end technology platform, known as the Operating System (OS), seamlessly orchestrates clinical trials directly from the patient’s home. The company provides a fully unified, global network of telemedicine investigators, mobile nursing units, and remote study coordinators, effectively turning any patient’s living room into a fully compliant clinical trial site.

This groundbreaking approach significantly enhances patient recruitment speeds, dramatically improves long-term trial retention rates, and ensures highly diverse patient populations that much more accurately reflect real-world demographics. Science 37 successfully supports a wide array of complex therapeutic areas, including central nervous system disorders, oncology, dermatology, and rare infectious diseases.

By permanently removing the traditional, burdensome barriers of site travel and geographical restrictions, Science 37 has proven unequivocally that virtual and hybrid trials are not only viable but often vastly superior in operational efficiency, data quality, and patient-centricity. The organization continues to partner with major biopharma companies to implement agile clinical designs that represent the undisputed future of medical research.